Cargando…
Molecular markers contribute to the clinical diagnosis for pancreatic cystic neoplasms
A pancreatic cystic neoplasm (PCN) is a rare pancreatic disease. Malignant PCNs are usually identified incidentally while evaluating other lesions. However, PCNs are being identified more frequently owing to the increased use of abdominal imaging. Malignant PCNs have complicated and diverse biologic...
Autores principales: | Liu, Zhen, Zhang, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147649/ https://www.ncbi.nlm.nih.gov/pubmed/32106125 http://dx.doi.org/10.1097/CM9.0000000000000716 |
Ejemplares similares
-
Pancreatic Cystic Neoplasms: Diagnosis and Management
por: Schubach, Abigail, et al.
Publicado: (2023) -
The Value of Serum Tumor Markers and Blood Inflammation Markers in Differentiating Pancreatic Serous Cystic Neoplasms and Pancreatic Mucinous Cystic Neoplasms
por: Wang, Huan, et al.
Publicado: (2022) -
Cystic pancreatic neoplasms
por: Francis, Isaac R.
Publicado: (2015) -
Pancreatic cystic neoplasm diagnosis: Role of imaging
por: Sarno, Alessandro, et al.
Publicado: (2018) -
Pancreatic Cystic Neoplasms: Translating Guidelines into Clinical Practice
por: Mohapatra, Sonmoon, et al.
Publicado: (2023)